Cargando…

Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis

BACKGROUND: Up to 5% of familial Mediterranean fever (FMF) cases are unresponsive to colchicine, through resistance, side effects and toxicity. Anakinra is an alternative treatment for FMF patients whose disease remains uncontrolled with colchicine. We aimed to evaluate anti-interleukin-1 treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sargin, Gokhan, Kose, Reyhan, Senturk, Taskin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Paulista de Medicina - APM 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721218/ https://www.ncbi.nlm.nih.gov/pubmed/31116269 http://dx.doi.org/10.1590/1516-3180.2018.0311101218

Ejemplares similares

Relationship between bone mineral density and anti-citrullinated protein antibody and rheumatoid factor in patients with rheumatoid arthritis
por: Sargın, Gökhan, et al.
Publicado: (2019)

Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases
por: Yücel, Burcu Bozkaya, et al.
Publicado: (2021)

A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever
por: Corsia, Alice, et al.
Publicado: (2017)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
por: Calligaris, Lorenzo, et al.
Publicado: (2007)

Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)
por: El Hasbani, Georges, et al.
Publicado: (2019)

Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever
por: Sener, Seher, et al.
Publicado: (2023)

Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine
por: Berdeli, Afig, et al.
Publicado: (2019)

Appendectomy history is associated with severe disease and colchicine resistance in adult familial Mediterranean fever patients
por: BODAKÇİ, Erdal, et al.
Publicado: (2021)

Colchicine-resistant familial Mediterranean fever in a renal transplantation patient: successful treatment with anakinra
por: Celebi, Zeynep Kendi, et al.
Publicado: (2014)

The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF)
por: Dandekar, P, et al.
Publicado: (2015)

IL1-blocking therapy in colchicine-resistant familial Mediterranean fever
por: Köhler, Birgit Maria, et al.
Publicado: (2018)

Remission of nephrotic syndrome in amyloidosis of familial Mediterranean fever following colchicine treatment
por: Odabas, Hatice
Publicado: (2006)

Does switching from coated colchicine to compressed colchicine improves treatment response in patients with familial Mediterranean fever?
por: Öner, Nimet, et al.
Publicado: (2023)

Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
por: Gül, Ahmet, et al.
Publicado: (2015)

Intestinal malrotation as a misdiagnosis of pediatric colchicine resistant familial Mediterranean fever
por: Heshin-Bekenstein, Merav, et al.
Publicado: (2015)

Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram
por: Toshida, Masamitsu, et al.
Publicado: (2021)

Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?
por: Omma, Ahmet, et al.
Publicado: (2021)

The Anxiety and Depression in Rheumatoid Arthritis Patients Treating with Disease-Modifying Anti-Rheumatic Drugs during the COVID-19 Pandemic
por: Sargın, Gökhan, et al.
Publicado: (2022)

Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
por: Omma, Ahmet, et al.
Publicado: (2017)

Left Atrial Myxoma Mimicking Polyarteritis Nodosa
por: Sargin, Gokhan, et al.
Publicado: (2015)

Multiple pulmonary rheumatoid nodules
por: Sargin, Gokhan, et al.
Publicado: (2015)

The role of albumin-to-globulin ratio in undifferentiated arthritis: Rheumatoid arthritis versus primary Sjögren syndrome
por: Köse Çobanoglu, Reyhan, et al.
Publicado: (2021)

Development of focal segmental glomerulosclerosis in a patient with Familial Mediterranean Fever resistant to colchicine therapy under treatment with Canakinumab
por: Barut, K, et al.
Publicado: (2015)

Genotype Mutations in Palestinian Children with Familial Mediterranean Fever: Clinical Profile, and Response to Colchicine Treatment: A Retrospective Cohort Study
por: Shrateh, Oadi N., et al.
Publicado: (2023)

The Characteristics of Pediatric Patients with Familial Mediterranean Fever Treated with Anti-Interleukin-1 Treatment
por: Avar Aydın, Pınar Özge, et al.
Publicado: (2022)

Comparison of Different Pharmaceutical Preparations of Colchicine in Children with Familial Mediterranean Fever: Is Colchicine Opocalcium a Good Alternative?
por: Türkuçar, Serkan, et al.
Publicado: (2021)

Chemotherapy-Colchicine Interaction in a Child with Familial Mediterranean Fever and Hodgkin Lymphoma
por: Langenberg-Ververgaert, Karin P.S., et al.
Publicado: (2018)

Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever
por: Verrecchia, E., et al.
Publicado: (2017)

18F-FDG PET/CT in the diagnosis of Takayasu’s arteritis
por: Sargin, Gokhan, et al.
Publicado: (2018)

Rhupus syndrome and Chiari's network
por: Sargin, Gokhan, et al.
Publicado: (2018)

The relationship between blood eosinophil count and disease activity in ankylosing spondylitis patients treated with TNF-α inhibitors
por: Sargin, Gokhan, et al.
Publicado: (2018)

The effects of distraction on symptoms during drug provocation test
por: CILDAG, SONGUL, et al.
Publicado: (2017)

Clinical and laboratory characteristics of chronic spontaneous urticaria with connective tissue diseases: A cross-sectional study
por: Çildağ, Songül, et al.
Publicado: (2021)

The effect of disease-modifying antirheumatic drugs on sleep and quality of life in older patients with rheumatoid arthritis
por: Azizli, Ali, et al.
Publicado: (2023)

Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
por: Hashkes, PJ, et al.
Publicado: (2011)

Coexistence of hereditary angioedema in a case of familial Mediterranean fever with partial response to colchicine
por: Bahceci, Semiha Erdem, et al.
Publicado: (2015)

Genotype Mutations in Egyptian Children with Familial Mediterranean Fever: Clinical Profile, and Response to Colchicine
por: Talaat, Hala S., et al.
Publicado: (2020)

Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review
por: Talerico, Rosa, et al.
Publicado: (2020)

COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review
por: Nas, Kemal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2p1al1s70u70a2nqr5novncg2m